Ben Eklund

Ben Eklund is a Scientist at SK pharmteco, where responsibilities include method transfer, R&D, GMP testing, and manufacturing for biopharmaceutical clients, particularly in cell and gene therapy. Eklund has contributed to the Testing & Analytical Services department by building testing platforms from the ground up, including writing and developing test methods. Prior to this role, Eklund served as an Associate Scientist at the Center for Breakthrough Medicines, which was acquired by SK pharmteco in September 2023, and worked as a Chemist I at The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on quality control testing for the pharmaceutical product Remicade. Eklund holds a Bachelor of Science in Biochemistry from Arizona State University, obtained in 2019.